ARSA (Search Result) Help

Search Result

Facet

Division

now loading

    Organism_facet

    now loading

      List of Entries

      1 - entries / Number of founds: 131  
        PrimaryAccessionNumber Definition SequenceLength MolecularType Organism
      MT695607 Miniopterus fuliginosus isolate N21104 D-loop, partial sequence; mitochondrial. 294 DNA Miniopterus fuliginosus
      N21104 yx52c05.s1 Soares melanocyte 2NbHM Homo sapiens cDNA clone IMAGE:265352 3' similar to gb:K00558 TUBULIN ALPHA-1 CHAIN (HUMAN), mRNA sequence. 474 mRNA Homo sapiens
      HZ525885 JP 2016501039-A/21104: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS. 40 DNA synthetic construct
      DD801374 JP 2008525033-A/21104: Group B Streptococcus. 242 PRT Streptococcus agalactiae
      DM795562 JP 2014068652-A/21104: NEISSERIAL ANTIGENIC PEPTIDES. 8 PRT Neisseria
      FU795585 JP 2009528046-A/21102: Method for identifying useful proteins of brewery yeast. 25 DNA Saccharomyces pastorianus
      MD267237 JP 2020517247-A/21104: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof. 20 DNA synthetic construct
      LV566926 JP 2017029159-A/21104: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS. 40 DNA synthetic construct
      PD709018 JP 2021530475-A/21100: De novo Design of Protein Switches. 56 PRT synthetic construct
      LX118720 JP 2017506877-A/21102: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes. 16 DNA synthetic construct
      LF680325 JP 2016521556-A/21104: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION. 15 DNA Homo sapiens
      HW186132 JP 2013102767-A/21056: Novel siRNA's and Use Thereof. 21 RNA synthetic construct
      DJ524904 JP 2010517930-A/21104: Method of constructing and screening libraries of peptide structures. 21 PRT synthetic construct
      OG505290 JP 2018534252-A/21104: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF. 34 PRT synthetic construct
      OG657490 JP 2021500321-A/21104: METHODS AND COMPOSITIONS FOR INHIBITING ADAM10 BIOLOGICAL ACTIVITIES. 189 PRT synthetic construct
      MC162948 JP 2019500349-A/21104: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES. 18 RNA synthetic construct
      PA391827 JP 2021533803-A/20910: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE. 26 DNA Homo sapiens
      MC549604 JP 2019525738-A/21104: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES. 8 PRT synthetic construct
      OG750623 JP 2021120380-A/21104: CANCER NEOEPITOPES. 9 PRT Homo sapiens
      LF828260 JP 2016528161-A/21093: COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS. 18 RNA synthetic construct
      DJ150484 JP 2007228956-A/21102: Method for identification of useful proteins derived from brewery yeast. 25 DNA Saccharomyces pastorianus
      PA336752 JP 2021522188-A/21104: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation. 20 DNA synthetic construct
      PA525588 JP 2022502046-A/8370: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY. 21 DNA synthetic construct
      DL902848 JP 2014205669-A/21104: Method of constructing and screening libraries of peptide structures. 21 PRT synthetic construct
      DJ952378 JP 2010500568-A/39059: ORGAN-SPECIFIC PROTEINS AND METHODS OF THEIR USE. 351 PRT Homo sapiens
      DM757798 JP 2014079248-A/21104: NEISSERIAL ANTIGENIC PEPTIDES. 8 PRT Neisseria
      MC773214 JP 2018525446-A/21104: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF. 33 PRT synthetic construct
      HV877645 JP 2010507387-A/21056: Novel siRNAs and Methods of Use Thereof. 21 RNA synthetic construct
      DL030118 JP 2005512499-A/21104: Diagnosis of existing illnesses or that praedisposition for determined illnesses. 820 DNA synthetic construct
      DL611706 JP 2011092200-A/21104: NEISSERIAL ANTIGENIC PEPTIDES. 8 PRT Neisseria
      Now loading
      PAGE TOP